Case number 1:20-cv-01760
Merz Pharmaceuticals, LLC et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 3, 2021 | 28 | Order (2) |
| Jun 3, 2021 | 28 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552; 7,816,396. (Attachments: # (1) Order)(nms) |
| Jun 3, 2021 | 27 | Order (2) Docket Text: SO ORDERED Granting [26] Joint Stipulation and Proposed Order of Dismissal Without Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 6/3/2021. (nms) |
| Jun 3, 2021 | 26 | Stipulation of Dismissal (2) Docket Text: JOINT Stipulation and Proposed Order of Dismissal Without Prejudice, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) Modified on 6/3/2021 (nms). |
| May 19, 2021 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Core Technical Documents filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| May 19, 2021 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Paragraph 3 Disclosures Pursuant to the Delaware Default Standard for Litigation Involving U.S. Patent Nos. 7,638,552 and 7,816,396 filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Joyce, Alexandra) |
| May 17, 2021 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Paragraph 3 Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| May 14, 2021 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Joyce, Alexandra) |
| May 14, 2021 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Rule 26(a)(1) Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| May 7, 2021 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Joyce, Alexandra) |
| May 6, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| May 6, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 5/6/2021. (dlb) |
| May 4, 2021 | 18 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties and Amendment of Pleadings due by 2/1/2022. Discovery due by 5/31/2022. Opening Expert Reports due by 7/15/2022. Rebuttal Expert Reports due by 8/26/2022. Expert Discovery due by 11/7/2022. A Status Conference is set for 10/14/2022 at 09:00 AM before Judge Richard G. Andrews. Interim Status Report due by 1/21/2022. Joint Claim Construction Brief due by 1/14/2022. A Markman Hearing is set for 2/23/2022 at 01:00 PM before Judge Jennifer L. Hall. Joint Proposed Pretrial Order due by 1/2/2023. A Pretrial Conference is set for 1/6/2023 at 09:00 AM before Judge Richard G. Andrews. A 3 day Bench Trial is set for 1/17/2023 at 08:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for complete details). Signed by Judge Jennifer L. Hall on 5/4/2021. (ceg) |
| Apr 27, 2021 | 16 | Proposed Order (12) Docket Text: PROPOSED Scheduling Order, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) Modified on 4/28/2021 (nms). |
| Apr 27, 2021 | 17 | Letter (1) Docket Text: Letter to The Honorable Jennifer L. Hall, from Daniel M. Silver, Esq., regarding proposed Scheduling Order. (Silver, Daniel) Modified on 4/28/2021 (nms). |
| Apr 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [15] Stipulation to Extend Time for the parties to file a Proposed Scheduling Order and related Letter to April 27, 2021. ORDERED by Judge Jennifer L. Hall on 4/7/2021. (ceg) |
| Apr 7, 2021 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a Proposed Scheduling Order and related Letter to April 27, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Mar 26, 2021 | 14 | Answer to Counterclaim (6) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by Merz North America, Inc., Merz Pharmaceuticals, LLC.(Silver, Daniel) |
| Mar 8, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent" up through and including paragraph number 17 (i.e., up to and including case dispositive motions) and consistent with paragraphs 13-16 of Judge Andrew's "Rule 16 Scheduling Order - Patent"; and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Orders can be found on Judge Hall's and Judge Andrew's portions of the District Court's website. ORDERED by Judge Jennifer L. Hall on 3/8/2021. (ceg) |
| Mar 8, 2021 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint , COUNTERCLAIM against Merz North America, Inc., Merz Pharmaceuticals, LLC by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd..(Dorsney, Kenneth) Modified on 3/8/2021 (ceg). |
| Mar 8, 2021 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Feb 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] Stipulation Regarding Venue and Personal Jurisdiction filed by Merz Pharmaceuticals, LLC, Merz North America, Inc. ORDERED by Judge Jennifer L. Hall on 2/2/2021. (ceg) |
| Feb 1, 2021 | 10 | Stipulation (3) Docket Text: STIPULATION Regarding Venue and Personal Jurisdiction, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Joyce, Alexandra) Modified on 2/1/2021 (nms). |
| Jan 13, 2021 | N/A | Order Referring Case to Magistrate Judge (0) Docket Text: ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. (nms) |
| Jan 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Jason A. Leonard and Vincent Li, filed by Merz Pharmaceuticals, LLC, Merz North America, Inc.. Signed by Judge Richard G. Andrews on 1/8/2021. (nms) |
| Jan 8, 2021 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merz Pharmaceuticals, LLC, Merz North America, Inc.: For Aurobindo Pharma Ltd. waiver sent on 1/6/2021, answer due 3/8/2021. (Silver, Daniel) |
| Jan 8, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merz Pharmaceuticals, LLC, Merz North America, Inc.: For Aurobindo Pharma USA Inc. waiver sent on 1/6/2021, answer due 3/8/2021. (Silver, Daniel) |
| Jan 8, 2021 | 8 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason A. Leonard and Vincent Li - filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 1/8/2021 (nms). |
| Jan 8, 2021 | 8 | Certifications for Jason A. Leonard and Vincent Li (2) |
| Dec 30, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Dec 23, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Dec 23, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merz Pharma GmbH & Co. KGaA, Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz, Incorporated for Merz North America, Inc., Merz Pharmaceuticals, LLC filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (myr) |
| Dec 23, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552 ;7,816,396. (myr) |
| Dec 23, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than November 16, 2020. Date of Expiration of Patent: 7,638,552 (August 20, 2023) 7,816,396 (August 20, 2023).Thirty Month Stay Deadline: No earlier than 5/16/2023. (myr) |
| Dec 23, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Dec 23, 2020 | 1 | Civil Cover Sheet (1) |
| Dec 23, 2020 | 1 | Exhibit B (12) |
| Dec 23, 2020 | 1 | Exhibit A (12) |
| Dec 23, 2020 | 1 | Complaint* (1) |
